Disengage too soon and we lose all the gains we have made to date

42 years into the AIDS epidemic and we have made impressive strides in the development and dissemination of HIV treatment and preventative measures, supported largely through initiatives like the President’s Emergency Plan for AIDS Relief, or PEPFAR. This we celebrate and are deeply grateful for. The impact of providing access to HIV treatment and preventative pre-exposure…

Details

Desmond Tutu Health Foundation sets the stage for LGBTQIA+ advocacy in Central Karoo

According to Statista, homosexuality is illegal in 32 African countries. While this is not the case in South Africa, where same sex marriage and joint child adoption is legal, the Lesbian, Gay, Bisexual, Transexual, Queer, Intersexual, Asexual+ (LGBTQIA+) community in the country still experiences high levels of systematic discrimination and societal exclusion based on their…

Details

Desmond Tutu Health Foundation strongly condemns signing of the Ugandan Anti-Homosexuality Act, 2023

On 29 May 2023 Ugandan President Yoweri Museveni signed the Anti-Homosexuality Act, 2023 into law, declaring consensual same-sex sexual activities and any “promotion” of homosexuality a punishable criminal offence. The new law incorporates penalties that include a death sentence for cases of sexual relations involving people infected with HIV, repeated offences, minors, and other vulnerable…

Details

Statement against the Ugandan Anti-Homosexuality Bill

We, the Desmond Tutu Health Foundation and partners, strongly condemn the Anti-Homosexuality Bill passed in the Ugandan Parliament on 21 March 2023. This a gross infringement of human rights and dignity and undermines sound public health policy. As an organisation in the name of the late Archbishop Emeritus Tutu, we are particularly concerned regarding the…

Details

Phase 3 Mosaic-Based Investigational HIV Vaccine Study Discontinued Following Disappointing Results of Planned Data Review

HVTN researchers and ethicists say findings will help guide new approaches to HIV vaccine studies SEATTLE (Wednesday, January 18, 2023) – A Phase 3 study of an investigational HIV vaccine regimen has been discontinued following a planned, interim review by the study’s independent Data and Safety Monitoring Board (DSMB) on Jan. 12, 2023. The Mosaico study – also…

Details

Joint statement against the assault of Thabiso Motaung

WEDNESDAY 18 JANUARY 2022. CAPE TOWN, SOUTH AFRICA: We, representing the LGTBQI+ civil society and allies in Cape Town, strongly condemn the physical assault and injustice committed against Thabiso Motaung, a 19-year-old transgender woman, in Khayelitsha. What occurred was a hate crime and is a violation of her basic human rights. We call for the…

Details

About the RETAIN study: Improving RETention and viral load outcomes for people taking Antiretroviral therapy through early IdentificatioN of missed doses

Too few South Africans living with HIV achieve viral suppression. Although advances in antiretroviral therapy (ART) have reduced illness and death for people with HIV (PWH), ongoing evidence show gaps in the HIV continuum, including poor tablet taking / adherence and low retention in care, particularly in the first 4 months after ART is started.…

Details